Rising AUD in 2020 and priced in Mcpil approval not materialising biggest risk. Latest hire didn’t seem to excite anyone.
- Forums
- ASX - By Stock
- Value
RRL
regis resources limited
Add to My Watchlist
0.44%
!
$4.53

Rising AUD in 2020 and priced in Mcpil approval not...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.53 |
Change
0.020(0.44%) |
Mkt cap ! $3.423B |
Open | High | Low | Value | Volume |
$4.51 | $4.54 | $4.43 | $16.75M | 3.715M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5083 | $4.48 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.55 | 150 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 7889 | 4.750 |
3 | 84 | 4.690 |
1 | 1 | 4.670 |
1 | 10 | 4.660 |
1 | 184 | 4.600 |
Price($) | Vol. | No. |
---|---|---|
4.340 | 106 | 1 |
4.550 | 150 | 1 |
4.560 | 583 | 1 |
4.570 | 445 | 2 |
4.580 | 6000 | 1 |
Last trade - 16.20pm 03/07/2025 (20 minute delay) ? |
Featured News
RRL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online